Company Filing History:
Years Active: 2002-2007
Title: Regina Draheim: Innovator in Medical Treatments
Introduction
Regina Draheim is a notable inventor based in Radebeul, Germany. She has made significant contributions to the field of medical treatments, particularly in the area of non-opiate analgesics and their applications for various health conditions. With a total of two patents to her name, Draheim's work has the potential to impact many lives.
Latest Patents
Draheim's latest patents include the use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases, including urge incontinence and urinary flow problems due to prostate hyperplasia. This invention aims to prevent, reverse, and medically treat lower urinary tract dysfunction, focusing on bladder instability and related diseases. Additionally, she has developed a patent for the use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines, showcasing her innovative approach to addressing complex medical issues.
Career Highlights
Throughout her career, Draheim has worked with prominent companies such as Elbion AG and Elbion GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Draheim has collaborated with notable colleagues, including Chris Rundfeldt and Hildegard Kuss, who have supported her innovative endeavors. Their combined efforts have further advanced the research and development of her patented technologies.
Conclusion
Regina Draheim's contributions to medical innovation through her patents reflect her dedication to improving health outcomes. Her work continues to pave the way for advancements in the treatment of various medical conditions.